Fund shareholders of XENETIC BIOSCIENCES INC
ISIN US9840156023 · United States · LEI 5493002WV0KYX8JXAH52
- Fund shareholders
- 4
- Of which ETFs
- 0 4 other funds
- Value held
- 51.4K $
- Share of capital
- 0.9 % of 2.3M shares on Jul 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 9,735 | 24.6K $ | 0.00 % | 0.42 % | as of Feb 28, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 6,731 | 18K $ | 0.29 % | as of Mar 31, 2026 ↗ | |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 2,070 | 5.2K $ | 0.09 % | as of Feb 28, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 1,388 | 3.5K $ | 0.06 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 4 | 0 | 19,924 | +17.7 % |
| 2026Q1 | 4 | 0 | 16,928 | -0.3 % |
| 2025Q4 | 4 | 0 | 16,976 | -15.5 % |
| 2025Q3 | 4 | 0 | 20,090 | -4.6 % |
| 2025Q2 | 4 | 0 | 21,051 | -1.0 % |
| 2025Q1 | 4 | 0 | 21,272 | -0.4 % |
| 2024Q4 | 4 | 0 | 21,348 | +4.1 % |
| 2024Q3 | 4 | 0 | 20,499 | -0.4 % |
| 2024Q2 | 4 | 0 | 20,571 | -0.2 % |
| 2024Q1 | 4 | 0 | 20,610 | +10.8 % |
| 2023Q4 | 4 | 18,598 |
Institutional managers
5 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 137,440 | 368.3K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 21,441 | 57.5K $ | as of Mar 31, 2026 |
| JTC Employer Solutions Trustee Ltd | 2,700 | 7 $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 806 | 2.2K $ | as of Mar 31, 2026 |
| Darwin Wealth Management, LLC | 2 | 5 $ | as of Mar 31, 2026 |
Declared shareholders of XENETIC BIOSCIENCES INC
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Renaissance Technologies LLC and 1 other | 6.00 % | 137,440 | as of Mar 31, 2026 · SCHEDULE 13G |
| MJL Manager LLC and 1 other | 5.50 % | 126,741 | as of May 22, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of XENETIC BIOSCIENCES INC". https://titelia.com/en/stocks/xenetic-biosciences-inc-US9840156023